Stock Events

Stock Events

Genflow Biosciences 

$0.039450
50
-$0.00-0% Tuesday 20:00

Statistics

Day High
0.027
Day Low
0.027
52W High
0.0545
52W Low
0.013
Volume
300,000
Avg. Volume
7,285
Mkt Cap
19.47M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-1.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GENFF. It's not an investment recommendation.
Lloyds Banking Group
13
LLOY.LSE
Barclays
13
BARC.LSE
BlackRock iShares S&P 500 Information Tech Sec UCITS USD (Acc)
13
IITU.LSE
iShares Global Clean Energy Transition UCITS
12
INRG.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurodegenerative diseases, similar to Genflow's interest in aging and age-related diseases.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has a strong portfolio in Alzheimer's disease, competing in the aging-related therapeutic area.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals works on treatments for eye diseases, inflammatory diseases, and cancer, overlapping with Genflow's focus on age-related conditions.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals is involved in treating cystic fibrosis and other serious diseases, competing in the broader biotech space for innovative therapies.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals focuses on RNAi therapeutics, a novel approach that could intersect with Genflow's work on genetic and cellular therapies.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is at the forefront of gene editing, a technology that could be applied to aging and age-related diseases.
Novartis
NVS
Mkt Cap292.35B
Novartis offers a broad range of healthcare solutions including treatments for aging-related diseases like cardiovascular conditions.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is known for its work in antiviral drugs and cancer, areas that are relevant to aging and age-related health issues.

About

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapies in the United Kingdom, Belgium, and the United States. It develops drugs in pre-clinical trial stage, including GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion for the treatment of metabolic associated steatohepatitis; GF-1003, a topical delivery of SIRT6 to the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005 for the treatment of mitochondrial dysfunction and sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company was founded in 2020 and is headquartered in London, the United Kingdom.
Show more...
CEO
Dr. Eric Jean Leire M.D., MBA
Country
United Kingdom
ISIN
GB00BP2C3V08
WKN
000A3DCSM

Listings

STU
DE
WQ5.STU
OTC Link
US
GENFF
F
DE
WQ5.F
LSE
GB
GENF.LSE

0 Comments

Share your thoughts

FAQ

What is Genflow Biosciences stock price today?▼
The current price of GENFF is $0.04 USD — it has decreased by -0% in the past 24 hours. Watch Genflow Biosciences stock price performance more closely on the chart.
What is Genflow Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Genflow Biosciences stocks are traded under the ticker GENFF.
Is Genflow Biosciences stock price growing?▼
GENFF stock has risen by +0% compared to the previous week, the month change is a +183.81% rise, over the last year Genflow Biosciences has showed a +119.17% increase.
What is Genflow Biosciences market cap?▼
Today Genflow Biosciences has the market capitalization of 19.47M
What is Genflow Biosciences revenue for the last year?▼
Genflow Biosciences revenue for the last year amounts to 0 USD.
What is Genflow Biosciences net income for the last year?▼
GENFF net income for the last year is -1.93M USD.
In which sector is Genflow Biosciences located?▼
Genflow Biosciences operates in the Health & Wellness sector.
When did Genflow Biosciences complete a stock split?▼
Genflow Biosciences has not had any recent stock splits.
Where is Genflow Biosciences headquartered?▼
Genflow Biosciences is headquartered in London, United Kingdom.